G-EYE colonoscopy is superior to standard colonoscopy for increasing adenoma detection rate: an international randomized controlled trial (with videos).


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
03 2019
Historique:
received: 14 03 2018
accepted: 20 09 2018
pubmed: 3 10 2018
medline: 14 6 2019
entrez: 2 10 2018
Statut: ppublish

Résumé

Colorectal cancer (CRC) is largely preventable with routine screening and surveillance colonoscopy; however, interval cancers arising from precancerous lesions missed by standard colonoscopy still occur. An increased adenoma detection rate (ADR) has been found to be inversely associated with interval cancers. The G-EYE device includes a reusable balloon integrated at the distal tip of a standard colonoscope, which flattens haustral folds, centralizes the colonoscope's optics, and reduces bowel slippage. The insufflated balloon also aims to enhance visualization of the colon during withdrawal, thereby increasing the ADR. In this randomized, controlled, international, multicenter study (11 centers), patients (aged ≥50 years) referred to colonoscopy for screening, surveillance, or changes in bowel habits were randomized to undergo either balloon-assisted colonoscopy by using an insufflated balloon during withdrawal or standard high-definition colonoscopy. The primary endpoint was the ADR. One thousand patients were enrolled between May 2014 and September 2016 to undergo colonoscopy by experienced endoscopists; 803 were finally analyzed (standard colonoscopy n = 396; balloon-assisted colonoscopy n = 407). Baseline parameters were similar in both groups. Balloon-assisted colonoscopy provided a 48.0% ADR compared with 37.5% in the standard colonoscopy group (28% increase; P = .0027). Additionally, balloon-assisted colonoscopy provided for a significant increase in detection of advanced (P = .0033) flat adenomas (P < .0001) and sessile serrated adenomas/polyps (P = .0026). Balloon-assisted colonoscopy yielded a higher ADR and increased the detection of advanced, flat, and sessile serrated adenomas/polyps when compared with standard colonoscopy. Improved detection by the G-EYE device could impact the quality of CRC screening by reducing miss rates and consequently reducing interval cancer incidence. (Clinical trial registration number: NCT01917513.).

Sections du résumé

BACKGROUND AND AIMS
Colorectal cancer (CRC) is largely preventable with routine screening and surveillance colonoscopy; however, interval cancers arising from precancerous lesions missed by standard colonoscopy still occur. An increased adenoma detection rate (ADR) has been found to be inversely associated with interval cancers. The G-EYE device includes a reusable balloon integrated at the distal tip of a standard colonoscope, which flattens haustral folds, centralizes the colonoscope's optics, and reduces bowel slippage. The insufflated balloon also aims to enhance visualization of the colon during withdrawal, thereby increasing the ADR.
METHODS
In this randomized, controlled, international, multicenter study (11 centers), patients (aged ≥50 years) referred to colonoscopy for screening, surveillance, or changes in bowel habits were randomized to undergo either balloon-assisted colonoscopy by using an insufflated balloon during withdrawal or standard high-definition colonoscopy. The primary endpoint was the ADR.
RESULTS
One thousand patients were enrolled between May 2014 and September 2016 to undergo colonoscopy by experienced endoscopists; 803 were finally analyzed (standard colonoscopy n = 396; balloon-assisted colonoscopy n = 407). Baseline parameters were similar in both groups. Balloon-assisted colonoscopy provided a 48.0% ADR compared with 37.5% in the standard colonoscopy group (28% increase; P = .0027). Additionally, balloon-assisted colonoscopy provided for a significant increase in detection of advanced (P = .0033) flat adenomas (P < .0001) and sessile serrated adenomas/polyps (P = .0026).
CONCLUSION
Balloon-assisted colonoscopy yielded a higher ADR and increased the detection of advanced, flat, and sessile serrated adenomas/polyps when compared with standard colonoscopy. Improved detection by the G-EYE device could impact the quality of CRC screening by reducing miss rates and consequently reducing interval cancer incidence. (Clinical trial registration number: NCT01917513.).

Identifiants

pubmed: 30273591
pii: S0016-5107(18)33138-9
doi: 10.1016/j.gie.2018.09.028
pii:
doi:

Substances chimiques

Hemoglobins 0

Banques de données

ClinicalTrials.gov
['NCT01917513']

Types de publication

Journal Article Randomized Controlled Trial Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-553

Informations de copyright

Copyright © 2019 American Society for Gastrointestinal Endoscopy. All rights reserved.

Auteurs

Haim Shirin (H)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Beni Shpak (B)

Gastroenterology and Liver Institute, Laniado Hospital, Netanya, Israel.

Julia Epshtein (J)

Gastroenterology and Liver Institute, Hadassah Medical Center, Jerusalem, Israel.

John Gásdal Karstensen (JG)

Gastroenterology Unit, Department of Surgery, Copenhagen University Hospital Herlev, Herlev, Denmark.

Arthur Hoffman (A)

Department of Gastroenterology and Endoscopy, Klinikum Osnabrueck, Osnabrueck, Germany.

Rogier de Ridder (R)

Endoscopy Department, UMC Maastricht, Maastricht, The Netherlands.

Pier Alberto Testoni (PA)

Division of Gastroenterology & GI Endoscopy, Vita Salute San Raffaele University-Scientific Institute San Raffaele, Milan, Italy.

Sauid Ishaq (S)

Department of Gastroenterology, Russells Hall Hospital, Dudley; Department of Health and Science, Birmingham City University, Birmingham, United Kingdom.

D Nageshwar Reddy (DN)

Gastroenterology Department, Asian Institute of Gastroenterology, Hyderabad, India.

Seth A Gross (SA)

Division of Gastroenterology and Hepatology, NYU Langone Medical Center, New York, NY, USA.

Helmut Neumann (H)

Department of Interdisciplinary Endoscopy, University Hospital Mainz, Mainz, Germany.

Martin Goetz (M)

Endoscopy Department, Universitätsklinikum Tübingen, Tübingen, Germany.

Dov Abramowich (D)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel.

Menachem Moshkowitz (M)

Gastroenterology and Liver Institute, Laniado Hospital, Netanya, Israel.

Meir Mizrahi (M)

Gastroenterology and Liver Institute, Hadassah Medical Center, Jerusalem, Israel; Advanced Endoscopy, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Medicine, Division of Gastroenterology and Hepatology, South Alabama University, Mobile, AL, USA.

Peter Vilmann (P)

Gastroenterology Unit, Department of Surgery, Copenhagen University Hospital Herlev, Herlev, Denmark.

Johannes Wilhelm Rey (JW)

Department of Gastroenterology and Endoscopy, Klinikum Osnabrueck, Osnabrueck, Germany.

Silvia Sanduleanu-Dascalescu (S)

Endoscopy Department, UMC Maastricht, Maastricht, The Netherlands.

Edi Viale (E)

Division of Gastroenterology & GI Endoscopy, Vita Salute San Raffaele University-Scientific Institute San Raffaele, Milan, Italy.

Hrushikesh Chaudhari (H)

Gastroenterology Department, Asian Institute of Gastroenterology, Hyderabad, India.

Mark B Pochapin (MB)

Division of Gastroenterology and Hepatology, NYU Langone Medical Center, New York, NY, USA.

Michael Yair (M)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel.

Mati Shnell (M)

Gastroenterology and Liver Institute, Laniado Hospital, Netanya, Israel.

Shaul Yaari (S)

Gastroenterology and Liver Institute, Hadassah Medical Center, Jerusalem, Israel.

Jakob Westergren Hendel (JW)

Gastroenterology Unit, Department of Surgery, Copenhagen University Hospital Herlev, Herlev, Denmark.

Daniel Teubner (D)

Department of Gastroenterology and Endoscopy, Klinikum Osnabrueck, Osnabrueck, Germany.

Roel M M Bogie (RMM)

Endoscopy Department, UMC Maastricht, Maastricht, The Netherlands.

Chiara Notaristefano (C)

Division of Gastroenterology & GI Endoscopy, Vita Salute San Raffaele University-Scientific Institute San Raffaele, Milan, Italy.

Roman Simantov (R)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel.

Nathan Gluck (N)

Gastroenterology and Liver Institute, Laniado Hospital, Netanya, Israel; Department of Gastroenterology and Hepatology, UMC Radboud, Nijmegen, Netherlands.

Eran Israeli (E)

Gastroenterology and Liver Institute, Hadassah Medical Center, Jerusalem, Israel.

Trine Stigaard (T)

Gastroenterology Unit, Department of Surgery, Copenhagen University Hospital Herlev, Herlev, Denmark.

Shay Matalon (S)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel.

Alexander Vilkin (A)

Gastroenterology and Liver Institute, Laniado Hospital, Netanya, Israel.

Ariel Benson (A)

Gastroenterology and Liver Institute, Hadassah Medical Center, Jerusalem, Israel.

Stine Sloth (S)

Gastroenterology Unit, Department of Surgery, Copenhagen University Hospital Herlev, Herlev, Denmark.

Amit Maliar (A)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel.

Amir Waizbard (A)

Gastroenterology and Liver Institute, Laniado Hospital, Netanya, Israel.

Harold Jacob (H)

Gastroenterology and Liver Institute, Hadassah Medical Center, Jerusalem, Israel.

Peter Thielsen (P)

Gastroenterology Unit, Department of Surgery, Copenhagen University Hospital Herlev, Herlev, Denmark.

Eyal Shachar (E)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel.

Shmuel Rochberger (S)

Gastroenterology and Liver Institute, Laniado Hospital, Netanya, Israel.

Tiberiu Hershcovici (T)

Gastroenterology and Liver Institute, Hadassah Medical Center, Jerusalem, Israel.

Julie Isabelle Plougmann (JI)

Gastroenterology Unit, Department of Surgery, Copenhagen University Hospital Herlev, Herlev, Denmark.

Michal Braverman (M)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel.

Eduard Tsvang (E)

Gastroenterology and Liver Institute, Hadassah Medical Center, Jerusalem, Israel.

Armita Armina Abedi (AA)

Gastroenterology Unit, Department of Surgery, Copenhagen University Hospital Herlev, Herlev, Denmark.

Yuri Brachman (Y)

Gastroenterology, Liver and Nutrition Institute, Assaf Harofeh Medical Center, Tzrifin, Israel.

Peter D Siersema (PD)

Department of Gastroenterology and Hepatology, UMC Radboud, Nijmegen, Netherlands.

Ralf Kiesslich (R)

Department of Gastroenterology and Endoscopy, Klinikum Osnabrueck, Osnabrueck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH